Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)

This study has been completed.

Study NCT00746447 Information provided by Dr. Falk Pharma GmbH

First Received: September 3, 2008 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2008
Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)